Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
24,446 total articles
Diana Shipping Inc., a major shareholder of Genco Shipping & Trading Limited, publicly opposes Genco's board decision to maintain a poison pill that blocks takeover attempts including Diana's all-cash offer. Diana encourages Genco shareholders to vote against the ratification of the poison pill and the equity incentive plan, and to support its nomi…
Akamai Technologies has unveiled its Agentic Security Framework, designed to secure and scale AI-driven digital interactions and commerce. The framework introduces the "Know Your Agent" protocol to verify AI agent identities linked to authorized human users, integrates with major partners like Visa, Experian, and Skyfire to establish trusted AI age…
Gilat Satellite Networks announced a $157.5 million acquisition of Comtech Telecommunications' Satellite & Space Communications segment. This strategic move significantly expands Gilat's scale in the satellite ground infrastructure market, more than doubles its defense revenues, and enhances its U.S. presence and technology portfolio, positioning t…
NIP Group Inc. plans to change the ratio of its American Depositary Shares (ADS) from one ADS representing two Class A ordinary shares to one ADS representing sixty Class A ordinary shares, effectively a one-for-thirty reverse ADS split. The change is expected to take effect around July 6, 2026, with no action required from ADS holders. The ADS wil…
OwlTing Group (NASDAQ: OWLS), a global fintech company, announced a new partnership with U.S. payment orchestration platform Credible Finance to open cross-border payment corridors starting with China and plans for India. This collaboration integrates Credible’s network with OwlTing’s regulated settlement infrastructure, OwlPay Harbor, enhancing cr…
WeRide, a leading autonomous driving tech company and publicly traded Robotaxi operator, achieved a historic sixth consecutive victory at the Second China Urban Intelligent Driving Competition with its WRD 3.0 driving system. The latest competition introduced stricter rules evaluating full-journey driving performance, including Parking-to-Parking N…
GEN Restaurant Group, Inc., operator of GEN Korean BBQ, has secured retail shelf space for its ready-to-cook marinated meat products in 254 Smart & Final store locations across California, Nevada, and Arizona. This move supports GEN's strategy to expand its retail footprint and bring its Korean BBQ experience into consumers' homes through packaged …
Fortuna Mining Corp. announced receipt of the environmental permit from the Senegalese Ministry of Environment for the Diamba Sud Gold Project, marking a critical milestone towards obtaining the full mining permit. The project, with robust preliminary economic assessment metrics including an after-tax IRR of 72% and NPV of $563 million, is progress…
Willis Towers Watson (WTW) has introduced an upgraded version of its Climate Diagnostic model integrated within its Risk IQ platform. This technology enhances the ability of risk managers and brokers to assess and respond to the increasing volatility and severity of climate-driven risks such as floods and windstorms that impact property insurance m…
InterDigital, Inc., a leader in wireless, video, and AI technologies, will highlight its latest advancements in interactive augmented reality experiences and energy-efficient video streaming at the 13th FOKUS Media Web Symposium. The company's AI-enabled Pixel Value Reduction technology promises to extend smartphone video watch time by improving en…
Red Cat Holdings, Inc. has introduced the Hellcat™, a new small unmanned aircraft system (sUAS) built on its proven Black Widow™ platform. Designed for flexible deployment in contested and GPS-denied environments, Hellcat incorporates extensive field feedback and supports modular, software-defined updates to meet evolving military mission needs. Th…
VAALCO Energy announced successful drilling results offshore Gabon and onshore Egypt, with the Ebouri-5H well producing over 8,000 gross barrels of oil per day and the HE-9 well in Egypt exceeding predrill production expectations. The company continues its drilling campaign with plans to reduce operational costs by utilizing natural gas and aims to…
IQE plc and Tower Semiconductor announced a multi-year agreement for the supply of Indium Phosphide (InP) epiwafers to support next-generation optical connectivity solutions in AI-driven data center infrastructure. The collaboration includes technology development for high-speed optical transceivers and modulators, with minimum purchase and supply …
Magnera Corporation announced the sale of its Caerphilly, UK operations, which produce metallized paper for premium labels, gift wrap, and food packaging, to Polyart Group, a portfolio company of Prudentia Capital. The sale follows a strategic review aiming to optimize Magnera's manufacturing technologies and product markets. Magnera will continue …
At the EHA2026 Congress, Ascentage Pharma presented multiple positive clinical updates for its core assets olverembatinib and lisaftoclax in treating hematologic cancers such as chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). Data highlighted effective responses, favorable safety profiles,…
Zymeworks Inc. announced new Phase 1 clinical trial data for their antibody-drug conjugate ZW191 targeting folate receptor alpha in patients with platinum-resistant ovarian cancer and endometrial cancer. The data demonstrate high confirmed objective response rates (78.6% in FRα-positive ovarian cancer and 47.4% in FRα-negative cases) and durable re…
Crinetics Pharmaceuticals presented positive Phase 2 clinical data showing their investigational oral drug Atumelnant significantly reduced androgen levels while enabling glucocorticoid dose reductions in adults with classic congenital adrenal hyperplasia (CAH). Additionally, initial Phase 1b/2a trial results in ACTH-dependent Cushing’s syndrome de…
Crinetics Pharmaceuticals presented up to two years of data from PATHFNDR-1 and PATHFNDR-2 open-label extension studies showing that PALSONIFY (paltusotine), an oral somatostatin receptor agonist, maintains stable IGF-1 levels, controls acromegaly symptoms, and stabilizes or reduces pituitary tumor volume. The data confirmed durable disease control…
Celldex Therapeutics presented long-term Phase 2 data demonstrating that barzolvolimab treatment yields rapid, significant, and durable improvements in angioedema symptoms among patients with moderate to severe chronic spontaneous urticaria (CSU). Up to 64% of patients remained angioedema-free seven months post-treatment, indicating potential disea…
Mineralys Therapeutics presented post hoc proteomic analysis data indicating that lorundrostat, an investigational aldosterone synthase inhibitor, significantly reduces biomarkers linked to heart failure risk in patients with uncontrolled hypertension. These findings support lorundrostat's therapeutic potential and coincide with ongoing FDA review.…
Upstream Bio presented new responder analyses from its Phase 2 VIBRANT trial demonstrating that Verekitug, a TSLP receptor antagonist administered every three months, achieved clinically meaningful improvements in nasal polyp score and multiple key symptoms in a significant majority of patients with chronic rhinosinusitis with nasal polyps (CRSwNP)…
Celldex Therapeutics reported positive Phase 1 clinical trial results for CDX-622, a novel bispecific antibody targeting soluble stem cell factor (SCF) and thymic stromal lymphopoietin (TSLP) pathways. The study demonstrated rapid, dose-dependent mast cell depletion and TSLP inhibition with good tolerability and safety in healthy participants, supp…
Legend Biotech presented encouraging early clinical data for LB2501, their investigational in vivo CD19/CD20 dual-targeting CAR-T therapy, showing 100% objective response and 83.3% complete response rates at the higher dose in a Phase 1 trial for relapsed/refractory B-cell non-Hodgkin lymphoma. The therapy demonstrated dose-dependent CAR-T expansio…
Ascendis Pharma announced positive Phase 3 PaTHway trial results demonstrating that TransCon PTH provides sustained normalization of biochemical markers, improved kidney function, bone density, and quality of life in adults with hypoparathyroidism over 182 weeks. The treatment enabled patients to discontinue conventional therapies such as active vi…
Agios Pharmaceuticals presented detailed results from its RISE UP Phase 3 trial of mitapivat, showing statistically significant hemoglobin improvement and clinically meaningful reductions in transfusion burden and sickle cell pain crises among responders. The data reinforces mitapivat's strong anti-hemolytic profile and potential to improve quality…
